Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
11.79
+0.06 (0.51%)
Jul 3, 2025, 1:00 PM - Market closed
Evolent Health Market Cap
Evolent Health has a market cap or net worth of $1.37 billion as of July 3, 2025. Its market cap has decreased by -45.76% in one year.
Market Cap
1.37B
Enterprise Value
1.99B
1-Year Change
-45.76%
Ranking
Category
Stock Price
$11.79
Market Cap Chart
Since June 5, 2015, Evolent Health's market cap has increased from $1.05B to $1.37B, an increase of 29.91%. That is a compound annual growth rate of 2.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 1.38B | 5.55% |
| Dec 31, 2024 | 1.31B | -65.47% |
| Dec 29, 2023 | 3.80B | 33.63% |
| Dec 30, 2022 | 2.84B | 14.85% |
| Dec 31, 2021 | 2.47B | 79.93% |
| Dec 31, 2020 | 1.38B | 79.57% |
| Dec 31, 2019 | 765.70M | -53.32% |
| Dec 31, 2018 | 1.64B | 72.46% |
| Dec 29, 2017 | 951.20M | -5.38% |
| Dec 30, 2016 | 1.01B | 40.70% |
| Dec 31, 2015 | 714.50M | -32.05% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |